{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:21:19Z","timestamp":1793924479799,"version":"4.8.0"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018]]},"DOI":"10.2169\/internalmedicine.9190-17","type":"journal-article","created":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T22:12:26Z","timestamp":1509487946000},"page":"269-271","source":"Crossref","is-referenced-by-count":4,"title":["Acute Cerebellar Ataxia Associated with Anti-glutamic Acid Decarboxylase Antibodies Mimicking Miller Fisher Syndrome"],"prefix":"10.2169","volume":"57","author":[{"given":"Yoshitsugu","family":"Nakamura","sequence":"first","affiliation":[{"name":"Division of Neurology, Department of Internal Medicine IV, Osaka Medical College, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideto","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Internal Medicine IV, Osaka Medical College, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Hosokawa","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Internal Medicine IV, Osaka Medical College, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushi","family":"Yamane","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Internal Medicine IV, Osaka Medical College, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimon","family":"Ishida","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Internal Medicine IV, Osaka Medical College, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiharu","family":"Kimura","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Internal Medicine IV, Osaka Medical College, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Pittock SJ, Yoshikawa H, Ahlskog JE, et al. Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc 81: 1207-1214, 2006.","DOI":"10.4065\/81.9.1207"},{"key":"2","unstructured":"2. Saiz A, Blanco Y, Sabater L, et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 131: 2553-2563, 2008."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Lancaster E, Dalmau J. Neuronal autoantigens--pathogenesis, associated disorders and antibody testing. Nat Rev Neurol 8: 380-390, 2012.","DOI":"10.1038\/nrneurol.2012.99"},{"key":"4","unstructured":"4. Mitoma H, Adhikari K, Aeschlimann D, et al. Consensus paper: neuroimmune mechanisms of cerebellar ataxias. Cerebellum 15: 213-232, 2016."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Mitoma H, Hadjivassiliou M, Honnorat J. Guidelines for treatment of immune-mediated cerebellar ataxias. Cerebellum Ataxias 2: 14, 2015.","DOI":"10.1186\/s40673-015-0034-y"},{"key":"6","unstructured":"6. Ari\u00f1o H, Gresa-Arribas N, Blanco Y, et al. Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy. JAMA Neurol 71: 1009-1016, 2014."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ishida K, Mitoma H, Song SY, et al. Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase. Ann Neurol 46: 263-267, 1999.","DOI":"10.1002\/1531-8249(199908)46:2<263::AID-ANA19>3.3.CO;2-S"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lauria G, Pareyson D, Pitzolu MG, Bazzigaluppi E. Excellent response to steroid treatment in anti-GAD cerebellar ataxia. Lancet Neurol 2: 634-635, 2003.","DOI":"10.1016\/S1474-4422(03)00534-9"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. di Biase L, Assenza G, Iorio R, et al. Efficacy of oral corticosteroids therapy in anti-glutamic acid decarboxylase antibodies cerebellar ataxia. Parkinsonism Relat Disord 30: 78-80, 2016.","DOI":"10.1016\/j.parkreldis.2016.05.020"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ishida K, Mitoma H, Wada Y, et al. Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia. J Neurol Neurosurg Psychiatry 78: 190-192, 2007.","DOI":"10.1136\/jnnp.2006.091116"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Jones AL, Flanagan EP, Pittock SJ, et al. Responses to and outcomes of treatment of autoimmune cerebellar ataxia in adults. JAMA Neurol 72: 1304-1312, 2015.","DOI":"10.1001\/jamaneurol.2015.2378"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ishida K, Mitoma H, Mizusawa H. Reversibility of cerebellar GABAergic synapse impairment induced by anti-glutamic acid decarboxylase autoantibodies. J Neurol Sci 271: 186-190, 2008.","DOI":"10.1016\/j.jns.2008.04.019"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Schmitz-H\u00fcbsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 66: 1717-1720, 2006.","DOI":"10.1212\/01.wnl.0000219042.60538.92"},{"key":"14","unstructured":"14. Berlit P, Rakicky J. The Miller Fisher syndrome. Review of the literature. J Clin Neuroophthalmol 12: 57-63, 1992."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mitoma H, Song SY, Ishida K, Yamakuni T, Kobayashi T, Mizusawa H. Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase. J Neurol Sci 175: 40-44, 2000.","DOI":"10.1016\/S0022-510X(00)00272-0"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Mitoma H, Ishida K, Shizuka-Ikeda M, Mizusawa H. Dual impairment of GABAA- and GABAB-receptor-mediated synaptic responses by autoantibodies to glutamic acid decarboxylase. J Neurol Sci 208: 51-56, 2003.","DOI":"10.1016\/S0022-510X(02)00423-9"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nanri K, Koizumi K, Mitoma H, et al. Classification of cerebellar atrophy using voxel-based morphometry and SPECT with an easy Z-score imaging system. Intern Med 49: 535-541, 2010.","DOI":"10.2169\/internalmedicine.49.2785"},{"key":"18","unstructured":"18. Molina W, Reyes E, Joshi N, Barrios A, Hernandez L. Maturation of the neuromuscular junction in masseters of human fetus. Rom J Morphol Embryol 51: 537-541, 2010."},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology 56: 1104-1106, 2001.","DOI":"10.1212\/WNL.56.8.1104"},{"key":"20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1365-2249.2002.01931.x","volume":"129","author":"M Costa","year":"2002","unstructured":"20. Costa M, Saiz A, Casamitjana R, et al. T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity. Clin Exp Immunol 129: 471-478, 2002.","journal-title":"Clinical & Experimental Immunology","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9104","issn-type":"print"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Mori M, Kuwabara S. Fisher syndrome. Curr Treat Options Neurol 13: 71-78, 2011.","DOI":"10.1007\/s11940-010-0103-8"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/2\/57_9190-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T11:48:16Z","timestamp":1570276096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/2\/57_9190-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9190-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}